Gastrointestinal (GI) cancer (CA) drugs approved by the US Food and Drug Administration (FDA): Clinical value and cost considerations.

被引：0
|
作者：
Jiang, Di Maria
Jang, Raymond Woo-Jun
Chan, Kelvin K.
Liu, Geoffrey
Amir, Eitan
Elimova, Elena
机构：
[1] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
[2] Princess Margaret Canc Ctr, Toronto, ON, Canada
[3] Univ Toronto, Odette Canc Ctr, Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada
[4] Princess Margaret Canc Ctr, Div Med Oncol & Hematol, Toronto, ON, Canada
[5] Princess Margaret Canc Ctr, Dept Med Oncol, Toronto, ON, Canada
[6] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.6619
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6619
引用
收藏
页数：2
相关论文
共 50 条
  • [11] A Survey of Survival Outcomes for Targeted Cancer Drugs Approved by the US Food and Drug Administration
    Qian He
    Qiu Li
    Fanzhen Lv
    Kenneth I. Kaitin
    Liming Shao
    Therapeutic Innovation & Regulatory Science, 2021, 55 : 676 - 684
  • [12] Communication of Survival Data in US Food and Drug Administration-Approved Labeling of Cancer Drugs
    Naci, Huseyin
    Guan, Xiaodong
    Woloshin, Steven
    Xu, Ziyue
    Wagner, Anita K.
    JAMA INTERNAL MEDICINE, 2021, 181 (11) : 1521 - 1522
  • [13] Clinical benefit of breast cancer drugs approved by the United States Food and Drug Administration
    Carlos Tapia, J.
    Molto, Consolacion
    Bujosa, Aida
    Templeton, Arnoud J.
    Barnadas, Agusti
    Amir, Eithan
    Tibau, Ariadna
    CANCER RESEARCH, 2020, 80 (04)
  • [14] Magnitude of Clinical Benefit of Cancer Drugs Approved by the US Food and Drug Administration Based on Single-Arm Trials
    Tibau, Ariadna
    Molto, Consolacion
    Borrell, Maria
    Del Paggio, Joseph C.
    Barnadas, Agusti
    Booth, Christopher M.
    Amir, Eitan
    JAMA ONCOLOGY, 2018, 4 (11) : 1610 - 1611
  • [15] Estimated costs of pivotal trials for US Food and drug administration (FDA)-approved oncology drugs, 2015-2017
    Hsiue, Emily
    Moore, Thomas J.
    Alexander, Caleb
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 321 - 321
  • [16] A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2021
    Kayki-Mutlu, Gizem
    Aksoyalp, Zinnet Sevval
    Wojnowski, Leszek
    Michel, Martin C.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2022, 395 (08) : 867 - 885
  • [17] A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2020
    Gizem Kayki-Mutlu
    Martin C. Michel
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2021, 394 : 839 - 852
  • [18] A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2023
    Gizem Kayki-Mutlu
    Zinnet Sevval Aksoyalp
    Leszek Wojnowski
    Martin C. Michel
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2024, 397 : 2949 - 2970
  • [19] A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2021
    Gizem Kayki-Mutlu
    Zinnet Sevval Aksoyalp
    Leszek Wojnowski
    Martin C. Michel
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2022, 395 : 867 - 885
  • [20] A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2024
    Zinnet Sevval Aksoyalp
    Gizem Kayki-Mutlu
    Leszek Wojnowski
    Martin C. Michel
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2025, 398 (5) : 5077 - 5099
12345